A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension

NCT01863953 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma
Ocular Hypertension

Interventions

DRUG: Fixed-Combination Bimatoprost/Brimonidine
DRUG: Bimatoprost Ophthalmic Solution 0.01%
DRUG: Vehicle Ophthalmic Solution
DRUG: Brimonidine Tartrate Ophthalmic Solution 0.2%

Sponsor

Allergan